General Information of Drug (ID: DMWJ6PT)

Drug Name
Tyrophostins Drug Info
Synonyms
CP-2005; Tyrophostins (cancer); WP-1130; Degrasyns (cancer), Callisto/MD Anderson Cancer Center; Jak2 and Bcr/Abl protein destabiliser (chronic myelogenous leukemia), MD Anderson Cancer Center; Tyrophostins (cancer), Callisto/MD Anderson Cancer Center; C-Myc/Bcr-Abl/Jak-2 inhibitors (cancer), MD Anderson Cancer Center/Callisto
Cross-matching ID
TTD Drug ID
D01BWJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Dilated cardiomyopathy 2.20 0.00e+0 86/96 (89.58%) DES;PLN;GNAS;...
Hypertrophic cardiomyopathy 2.16 0.00e+0 81/90 (90%) DES;IL6;SGCG;...
Cardiac muscle contraction 2.10 0.00e+0 64/87 (73.56%) ATP2A2;TPM3;MYL3;...
Ribosome 1.90 1.49e-2 113/158 (71.52%) RPS26;MRPL33;RPS27L;...
Adrenergic signaling in cardiomyocytes 1.87 1.91e-2 130/150 (86.67%) PPP1R1A;PLN;ATP2B4;...
DNA replication 1.85 1.59e-2 34/36 (94.44%) PCNA;POLA2;POLE2;...
Lysosome -1.65 4.96e-2 115/128 (89.84%) AP1G2;LAMP1;AP3M2;...
Intestinal immune network for IgA production -1.68 3.98e-2 38/48 (79.17%) HLA-DRB1;HLA-DMB;HLA-DPA1;...
Asthma -1.68 4.14e-2 25/31 (80.65%) HLA-DRB1;HLA-DMB;HLA-DPA1;...
Fatty acid elongation -1.72 2.62e-2 19/27 (70.37%) TECR;ELOVL4;HADHA;...
Tuberculosis -1.72 2.77e-2 159/180 (88.33%) ITGB2;IL18;MAPK1;...
Toxoplasmosis -1.75 2.56e-2 103/112 (91.96%) GNAI1;LAMB3;CHUK;...
Type I diabetes mellitus -1.77 2.13e-2 38/43 (88.37%) HLA-E;HLA-F;ICA1;...
Graft-versus-host disease -1.80 1.52e-2 32/42 (76.19%) TNF;IFNG;HLA-B;...
Leishmaniasis -1.80 1.60e-2 67/77 (87.01%) ITGB2;MAPK1;FCGR2A;...
Ferroptosis -1.82 1.46e-2 36/41 (87.8%) ALOX15;MAP1LC3B;TP53;...
Systemic lupus erythematosus -1.83 1.42e-2 45/135 (33.33%) C1S;HLA-DRB1;HLA-DMB;...
Staphylococcus aureus infection -1.85 1.36e-2 72/95 (75.79%) KRT16;FCGR3B;CFH;...
Autoimmune thyroid disease -1.87 1.28e-2 46/53 (86.79%) HLA-E;HLA-F;HLA-DRB1;...
Phagosome -1.97 5.69e-3 118/152 (77.63%) SEC61B;ATP6V1G1;FCGR2B;...
Allograft rejection -2.02 0.00e+0 32/38 (84.21%) HLA-E;HLA-F;HLA-DRB1;...
Antigen processing and presentation -2.02 0.00e+0 60/78 (76.92%) CANX;TNF;IFNG;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 1.11uM - 10uM 24H